Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-02-2016 | Retinal Disorders

25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears

Authors: John C. Randolph, Rocio I. Diaz, Eric J. Sigler, Jorge I. Calzada, Steve Charles

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 2/2016

Abstract

Purpose

The purpose of this study was to describe the treatment of giant retinal tears (GRTs) with 25-gauge pars plana vitrectomy (PPV) and medium-term postoperative perfluoro-n-octane (MT-PFO).

Methods

The study was a retrospective interventional case series of consecutive patients with GRTs treated with 25-gauge PPV and postoperative MT-PFO for a period of 2–3 weeks. A second, staged procedure was performed in all patients for PFO removal.

Results

Twenty-three eyes of 22 patients were studied, with a mean follow-up of 33.04 ± 19.74 months. Successful reattachment was achieved in 91.3 % of eyes (21/23) after MT-PFO. Retinal re-detachment occurred in five eyes, which was caused by proliferative vitreoretinopathy. Additional complications included cataract progression (n = 10), foreign body response (30.4 %, 7/23), and transient intraocular pressure (IOP) elevation (8/23, 34.8 %). Transient IOP elevation was associated with worse visual outcome (p = 0.01).

Conclusions

MT-PFO was found to be an effective and safe technique for operative management of GRTs. In the majority of patients, retinas remained attached without further surgical intervention. Cataract progression, intraocular inflammation, and associated increased intraocular pressure are potential complications of MT-PFO.

Girard P, Boscher C, Navarro F, Forest A (1984) Retinal detachments caused by giant tear. J Fr Ophtalmol 7(3):205–209PubMed

Glaser BM (1986) Treatment of giant retinal tears combined with proliferative vitreoretinopathy. Ophthalmology 93(9):1193–1197PubMedCrossRef

Scott IU, Murray TG, Flynn HW Jr, Feuer WJ, Schiffman JC, Perfluoron Study G (2002) Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology 109(10):1828–1833PubMedCrossRef

Sigler EJ, Randolph JC, Calzada JI, Charles S (2013) 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane tamponade for inferior retinal detachment. Ophthalmic Surg Lasers Imaging Retina 44(1):34–40. doi:10.3928/23258160-20121221-10 PubMedCrossRef

Sigler EJ, Randolph JC, Calzada JI, Charles S (2013) Pars plana vitrectomy with medium-term postoperative perfluoro-N-octane for recurrent inferior retinal detachment complicated by advanced proliferative vitreoretinopathy. Retina 33(4):791–797. doi:10.1097/IAE.0b013e31826a6978 PubMedCrossRef

Rofail M, Lee LR (2005) Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears. Retina 25(7):897–901PubMedCrossRef

Sirimaharaj M, Balachandran C, Chan WC, Hunyor AP, Chang AA, Gregory-Roberts J, Hunyor AB, Playfair TJ (2005) Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears. Br J Ophthalmol 89(9):1176–1179. doi:10.1136/bjo.2004.065409 PubMedPubMedCentralCrossRef

Drury B, Bourke RD (2011) Short-term intraocular tamponade with perfluorocarbon heavy liquid. Br J Ophthalmol 95(5):694–698. doi:10.1136/bjo.2009.175216 PubMedCrossRef

Rush R, Sheth S, Surka S, Ho I, Gregory-Roberts J (2012) Postoperative perfluoro-N-octane tamponade for primary retinal detachment repair. Retina 32(6):1114–1120. doi:10.1097/IAE.0b013e31822f56f6 PubMedCrossRef

10.

Charles S, Calzada J, Wood B (2011) General posterior segment techniques. In: Pine J (ed) Vitreous microsurgery, 5th edn. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, pp 58–64

11.

Charles S, Calzada J, Wood B (2011) Giant breaks. In: Pine J (ed) Vitreous microsurgery, 5th edn. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, pp 138–143

12.

Charles S (2004) An engineering approach to vitreoretinal surgery. Retina 24(3):435–444PubMedCrossRef

13.

Sigler EJ, Charles S, Calzada JI (2014) Interface vitrectomy. Retina 34(3):616–617. doi:10.1097/IAE.0000000000000091 PubMedCrossRef

14.

The Retina Society Terminology Committee (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90(2):121–125

15.

Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516PubMedCrossRef

16.

Chen CH, Tsai MH, Su CC, Kou HK, Kao ML, Tsai SH, Chen YJ (2001) Results of 12-year clinical study of giant retinal tear. Chang Gung Med J 24(10):633–639PubMed

17.

Goezinne F, La Heij EC, Berendschot TT, Gast ST, Liem AT, Lundqvist IL, Hendrikse F (2008) Low redetachment rate due to encircling scleral buckle in giant retinal tears treated with vitrectomy and silicone oil. Retina 28(3):485–492. doi:10.1097/IAE.0b013e318150d879 PubMedCrossRef

18.

Leaver PK, Billington BM (1989) Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: 5 years follow-up. Graefes Arch Clin Exp Ophthalmol 227(4):323–327PubMedCrossRef

19.

Camacho H, Bajaire B, Mejia LF (1992) Silicone oil in the management of giant retinal tears. Ann Ophthalmol 24(2):45–49PubMed

20.

Karel I, Michalickova M, Soucek P (1996) Long-term results of pars plana vitrectomy and silicone oil for giant tears. Eur J Ophthalmol 6(3):315–321PubMed

21.

Unlu N, Kocaoglan H, Acar MA, Sargin M, Aslan BS, Duman S (2003) The management of giant retinal tears with silicone oil. Eur J Ophthalmol 13(2):192–195PubMed

22.

Hoffman ME, Sorr EM (1986) Management of giant retinal tears without scleral buckling. Retina 6(4):197–204PubMedCrossRef

23.

Batman C, Cekic O (1999) Vitrectomy with silicone oil or long-acting gas in eyes with giant retinal tears: long-term follow-up of a randomized clinical trial. Retina 19(3):188–192PubMed

24.

Al-Khairi AM, Al-Kahtani E, Kangave D, Abu El-Asrar AM (2008) Prognostic factors associated with outcomes after giant retinal tear management using perfluorocarbon liquids. Eur J Ophthalmol 18(2):270–277PubMed

25.

Sigler EJ, Randolph JC, Charles S (2014) Foreign body response within postoperative perfluoro-N-octane for retinal detachment repair: clinical features, grading system, and histopathology. Retina 34(2):237–246. doi:10.1097/IAE.0b013e31829d002e PubMedCrossRef

26.

Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11(4):367–374PubMedCrossRef

27.

Elsing SH, Fekrat S, Green WR, Chang S, Wajer SD, Haller JA (2001) Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid. Ophthalmology 108(1):45–48PubMedCrossRef

28.

Aylward GW, Cooling RJ, Leaver PK (1993) Trauma-induced retinal detachment associated with giant retinal tears. Retina 13(2):136–141PubMedCrossRef

Title: 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears
Authors: John C. Randolph
Rocio I. Diaz
Eric J. Sigler
Jorge I. Calzada
Steve Charles
Publication date: 01-02-2016
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 2/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-015-3049-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2016

Retinal structure in young patients aged 10 years or less with Best vitelliform macular dystrophy

Influence of optic disc leakage on objective optic nerve head assessment in patients with uveitis

Effect of rebamipide ophthalmic suspension on the success of lacrimal stent intubation

Steady-state multifocal visual evoked potential (ssmfVEP) using dartboard stimulation as a possible tool for objective visual field assessment

Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study

Effect of different culture media and deswelling agents on survival of human corneal endothelial and epithelial cells in vitro